Roberto Latagliata - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Roberto Latagliata

This paper is made freely available by the publisher.

2023 Francesca Palandri

ORCID

, Elena Rossi, Giuseppe Auteri

ORCID

, Massimo Breccia

ORCID

, Simona Paglia, Giulia Benevolo

ORCID

, Elena M. Elli

ORCID

, Francesco Cavazzini, Gianni Binotto, Alessia Tieghi, Mario Tiribelli

ORCID

, Florian H. Heidel

ORCID

, Massimiliano Bonifacio

ORCID

, Novella Pugliese

ORCID

, Giovanni Caocci

ORCID

and 22 other authors

Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2021 Francesca Palandri

ORCID

, Mario Tiribelli

ORCID

, Massimo Breccia

ORCID

, Daniela Bartoletti

ORCID

, Elena M. Elli, Giulia Benevolo

ORCID

, Bruno Martino, Francesco Cavazzini, Alessia Tieghi, Alessandra Iurlo

ORCID

, Elisabetta Abruzzese

ORCID

, Novella Pugliese

ORCID

, Gianni Binotto, Giovanni Caocci, Giuseppe Auteri

ORCID

and 20 other authors

Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome

Upload

This paper was not found in any repository, but could be made available legally by the author.

Roberto Latagliata

ORCID

, Immacolata Attolico, Malgorzata Monika Trawinska, Isabella Capodanno, Mario Annunziata, Chiara Elena, Luigiana Luciano, Monica Crugnola, Micaela Bergamaschi, Massimiliano Bonifacio

ORCID

, Claudia Baratè, Endri Mauro, Gianni Binotto, Nicola Sgherza, Chiara Aguzzi and 14 other authors

Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors

Upload

This paper was not found in any repository, but could be made available legally by the author.

Giulia Benevolo, Elena M. Elli, Daniela Bartoletti

ORCID

, Roberto Latagliata

ORCID

, Mario Tiribelli, Florian H. Heidel, Francesco Cavazzini, Massimiliano Bonifacio

ORCID

, Monica Crugnola, Gianni Binotto, Alessandra D'Addio, Alessia Tieghi, Micaela Bergamaschi, Giovanni Caocci

ORCID

, Nicola Polverelli

ORCID

and 13 other authors

Impact of Comorbidities and Body Mass Index on the Outcome of Polycythemia Vera Patients

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Mg Mazzucconi, Ermina Baldacci, Roberto Latagliata

ORCID

, Massimo Breccia, Francesca Paoloni, Ambra Di Veroli, Michele Cedrone, Barbara Anaclerico, Nicoletta Villivà, Raffaele Porrini, Enrico Montefusco, Alessandro Andriani, Marco Montanaro, Laura Scaramucci, Antonio Spadea and 4 other authors

Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the ‘Ph1‐negative Myeloproliferative Neoplasms Latium Group’

Upload

This paper was not found in any repository, but could be made available legally by the author.

Laura Cesini

ORCID

, Camilla Frieri, Claudia Baratè, Federica Sorà, Massimiliano Bonifacio, Marco Cerrano

ORCID

, Antonia Cagnetta, Chiara Elena, Lara Aprile, Nicola Sgherza, Malgorzata Trawinska, Antonella Gozzini, Isabella Capodanno

ORCID

, Monica Crugnola, Ida Carmosino and 10 other authors

Erythropoietin Treatment in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Frontline Imatinib who Developed Late Anemia

Upload

This paper was not found in any repository, but could be made available legally by the author.

Francesca Palandri

ORCID

, Massimo Breccia

ORCID

, Mario Tiribelli, Massimiliano Bonifacio, Giulia Benevolo, Alessandra Iurlo, Elena M. Elli, Gianni Binotto, Alessia Tieghi, Nicola Polverelli

ORCID

, Bruno Martino, Elisabetta Abruzzese, Micaela Bergamaschi, Florian H. Heidel, Francesco Cavazzini and 18 other authors

Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real‐world data

Upload

This paper was not found in any repository, but could be made available legally by the author.

Roberto Latagliata

ORCID

, Pasquale Niscola, Luana Fianchi, Maria Antonietta Aloe Spiriti, Aloe Spiriti, Luca Maurillo

ORCID

, Ida Carmosino, Laura Cesini, Chiara Sarlo, Annalina Piccioni, Alessia Campagna, Maria Lucia De Luca, Daniela De Benedittis, Marco Mancini, Massimo Breccia

ORCID

and 8 other authors

Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Francesca Palandri

ORCID

, Massimo Breccia

ORCID

, Massimiliano Bonifacio, Nicola Polverelli, Elena M. Elli, Giulia Benevolo

ORCID

, Mario Tiribelli

ORCID

, Elisabetta Abruzzese

ORCID

, Alessandra Iurlo, Florian H. Heidel, Micaela Bergamaschi, Alessia Tieghi, Monica Crugnola, Francesco Cavazzini, Gianni Binotto and 21 other authors

Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis

Upload

This paper was not found in any repository, but could be made available legally by the author.

Gioia Colafigli, Emilia Scalzulli, Marika Porrazzo, Daniela Diverio, Maria Giovanna Loglisci, Roberto Latagliata

ORCID

, Anna Guarini, Robin Foà, Massimo Breccia

ORCID

Digital droplet PCR at the time of TKI discontinuation in chronic‐phase chronic myeloid leukemia patients is predictive of treatment‐free remission outcome

Upload

This paper was not found in any repository, but could be made available legally by the author.

Elena Maria Elli

ORCID

ORCID

, Rossella Calori, Carlo Gambacorti-Passerini, Ida Carmosino, Massimo Breccia, Ambra Di Veroli, Roberto Latagliata

ORCID

Management and outcome of 11 pregnancies in women with polycythemia vera

Upload

This paper was not found in any repository, but could be made available legally by the author.

Alessandro Andriani, Elena Elli, Giulio Trapè, Nicoletta Villivà, Luana Fianchi, Ambra Di Veroli

ORCID

, Pasquale Niscola, Antonia Centra, Barbara Anaclerico, Guido Montanaro, Vincenza Martini, Andrea Aroldi, Ida Carmosino, Maria Teresa Voso, Massimo Breccia and 3 other authors

Treatment of Philadelphia‐negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors

Upload

This paper was not found in any repository, but could be made available legally by the author.

Francesca Palandri

ORCID

, Giuseppe A. Palumbo, Elisabetta Abruzzese, Alessandra Iurlo

ORCID

, Nicola Polverelli

ORCID

, Elena Elli, Massimiliano Bonifacio, Micaela Bergamaschi, Bruno Martino, Mario Tiribelli, Giulia Benevolo, Alessia Tieghi, Nicola Sgherza, Alessandro Isidori, Gianni Binotto and 15 other authors

Impact of 2016‐WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

Upload

This paper was not found in any repository, but could be made available legally by the author.

Laura Cesini, Ida Carmosino, Massimo Breccia, Daniela De Benedittis, Sara Mohamed, Maria Lucia De Luca, Gioia Colafigli, Matteo Molica, Emilia Scalzulli, Fulvio Massaro, Elena Mariggiò, Lorenzo Rizzo, Maria Giovanna Loglisci, Maria Cristina Scamuffa, Federico Vozella and 5 other authors

Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Roberto Latagliata

ORCID

, Massimo Breccia, Ida Carmosino, Laura Cesini

ORCID

, Daniela De Benedittis, Sara Mohamed, Federico Vozella, Matteo Molica, Melissa Campanelli, Maria Lucia De Luca, Gioia Colafigli, Luisa Quattrocchi, Maria Giovanna Loglisci, Fulvio Massaro, Martina Canichella and 4 other authors

Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?

Upload

This paper was not found in any repository, but could be made available legally by the author.

2017 Matteo Molica

ORCID

, Martina Canichella, Danilo Alunni Fegatelli, Gioia Colafigli, Fulvio Massaro, Roberto Latagliata

ORCID

, Robin Foà, Massimo Breccia

ORCID

The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials

Upload

This paper was not found in any repository, but could be made available legally by the author.

Massimo Breccia

ORCID

, Gioia Colafigli, Matteo Molica, Emilia Scalzulli, Daniela Diverio, Roberto Latagliata

ORCID

, Anna Guarini, Robin Foà

Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life

Upload

This paper is made freely available by the publisher.

Rena Buckstein

ORCID

, Enrico Balleari, Richard Wells, Valeria Santini

ORCID

, Alessandro Sanna, Chiara Salvetti, Elena Crisà

ORCID

, Bernardino Allione, Paolo Danise, Carlo Finelli, Marino Clavio, Antonella Poloni, Flavia Salvi, Daniela Cilloni, Esther Natalie Oliva and 20 other authors

ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems

Download from api.wiley.com

Missing publications? Search for publications with a matching author name.